274 related articles for article (PubMed ID: 32748462)
1. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
2. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
3. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
4. Sex differences exist in adult heart group 2 innate lymphoid cells.
Peng H; Wu S; Wang S; Yang Q; Wang L; Zhang S; Huang M; Li Y; Xiong P; Zhang Z; Cai Y; Li L; Deng Y; Deng Y
BMC Immunol; 2022 Oct; 23(1):52. PubMed ID: 36316644
[TBL] [Abstract][Full Text] [Related]
5. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients.
Sugita K; Steer CA; Martinez-Gonzalez I; Altunbulakli C; Morita H; Castro-Giner F; Kubo T; Wawrzyniak P; Rückert B; Sudo K; Nakae S; Matsumoto K; O'Mahony L; Akdis M; Takei F; Akdis CA
J Allergy Clin Immunol; 2018 Jan; 141(1):300-310.e11. PubMed ID: 28392332
[TBL] [Abstract][Full Text] [Related]
6. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
7. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
8. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.
Golebski K; Layhadi JA; Sahiner U; Steveling-Klein EH; Lenormand MM; Li RCY; Bal SM; Heesters BA; Vilà-Nadal G; Hunewald O; Montamat G; He FQ; Ollert M; Fedina O; Lao-Araya M; Vijverberg SJH; Maitland-van der Zee AH; van Drunen CM; Fokkens WJ; Durham SR; Spits H; Shamji MH
Immunity; 2021 Feb; 54(2):291-307.e7. PubMed ID: 33450188
[TBL] [Abstract][Full Text] [Related]
9. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
10. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
11. Lung group 2 innate lymphoid cells differentially depend on local IL-7 for their distribution, activation, and maintenance in innate and adaptive immunity-mediated airway inflammation.
Takami D; Abe S; Shimba A; Asahi T; Cui G; Tani-Ichi S; Hara T; Miyata K; Ikutani M; Takatsu K; Oike Y; Ikuta K
Int Immunol; 2023 Nov; 35(11):513-530. PubMed ID: 37493250
[TBL] [Abstract][Full Text] [Related]
12. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production.
Doherty TA; Khorram N; Lund S; Mehta AK; Croft M; Broide DH
J Allergy Clin Immunol; 2013 Jul; 132(1):205-13. PubMed ID: 23688412
[TBL] [Abstract][Full Text] [Related]
13. IL-13
Jia Y; Fang X; Zhu X; Bai C; Zhu L; Jin M; Wang X; Hu M; Tang R; Chen Z
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):675-683. PubMed ID: 27314535
[TBL] [Abstract][Full Text] [Related]
14. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor.
Wang YM; Shaw K; Zhang GY; Chung EYM; Hu M; Cao Q; Wang Y; Zheng G; Wu H; Chadban SJ; McCarthy HJ; Harris DCH; Mackay F; Grey ST; Alexander SI
J Am Soc Nephrol; 2022 May; 33(5):966-984. PubMed ID: 35387873
[TBL] [Abstract][Full Text] [Related]
16. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions.
Mantani PT; Dunér P; Ljungcrantz I; Nilsson J; Björkbacka H; Fredrikson GN
BMC Immunol; 2019 Dec; 20(1):47. PubMed ID: 31823769
[TBL] [Abstract][Full Text] [Related]
17. Topical Application of the Quaternary Ammonium Compound Didecyldimethylammonium Chloride Activates Type 2 Innate Lymphoid Cells and Initiates a Mixed-Type Allergic Response.
Shane HL; Lukomska E; Kashon ML; Anderson SE
Toxicol Sci; 2019 Apr; 168(2):508-518. PubMed ID: 30649503
[TBL] [Abstract][Full Text] [Related]
18. IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival.
Huang Q; Ma X; Wang Y; Niu Z; Wang R; Yang F; Wu M; Liang G; Rong P; Wang H; Harris DC; Wang W; Cao Q
EMBO Mol Med; 2020 Nov; 12(11):e12305. PubMed ID: 33034128
[TBL] [Abstract][Full Text] [Related]
19. Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity.
Yue J; Guo H; Xu P; Ma J; Shi W; Wu Y
Cancer Immunol Immunother; 2024 Mar; 73(4):65. PubMed ID: 38430390
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.
Flamar AL; Klose CSN; Moeller JB; Mahlakõiv T; Bessman NJ; Zhang W; Moriyama S; Stokic-Trtica V; Rankin LC; Putzel GG; Rodewald HR; He Z; Chen L; Lira SA; Karsenty G; Artis D
Immunity; 2020 Apr; 52(4):606-619.e6. PubMed ID: 32160524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
